This disparity highlights the heterogeneity in the pathophysiology of RCC-associated hypercalcemia and reinforces the importance of comprehensive diagnostic evaluation that includes measurements of PTH, PTHrP, and vitamin D metabolites. This evidence concerns the gene PTHLH and hypercalcemia disease.